Statement Of Changes In Equity [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183076

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	33 687 EUR	—	—	—	—	19 934 EUR	396 254 EUR	41 228 EUR	408 647 EUR	—	336 633 EUR	2 545 EUR	340 769 EUR	—	33 840 EUR	—	32 250 EUR	—	—	—	219 759 EUR	332 535 EUR	31 271 EUR	13 690 EUR	157 737 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	59 620 EUR	59 620 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	116 875 EUR	116 875 EUR	—	—	—	—	—
Other comprehensive income	—	—	—	18 298 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	17 300 EUR	—	—	—	—	—	—
Comprehensive income	—	- EUR	18 298 EUR	77 918 EUR	59 620 EUR	—	—	—	—	- EUR	—	—	—	17 300 EUR	—	- EUR	—	- EUR	134 175 EUR	116 875 EUR	—	—	—	—	—
Issue of equity	—	2 834 EUR	—	23,339,000 EUR	—	—	—	—	—	20,505,000 EUR	—	—	—	—	—	749,000 EUR	—	2 752 EUR	3 501 EUR	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	909,000 EUR	909,000 EUR	—	—	—	—	—	—	—	—	—	1 065 EUR	—	—	—	—	1 065 EUR	—	—	—	—	—	—